Albanell Mestres, J., & Rojo, F. (2022). Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2-advanced breast cancer: GEICAM/2014-12 (FLIPPER).
Chicago Style CitationAlbanell Mestres, Joan, and Federico Rojo. Randomized Phase II Study of Fulvestrant Plus Palbociclib or Placebo in Endocrine-sensitive, Hormone Receptor-positive/HER2-advanced Breast Cancer: GEICAM/2014-12 (FLIPPER). 2022.
MLA CitationAlbanell Mestres, Joan, and Federico Rojo. Randomized Phase II Study of Fulvestrant Plus Palbociclib or Placebo in Endocrine-sensitive, Hormone Receptor-positive/HER2-advanced Breast Cancer: GEICAM/2014-12 (FLIPPER). 2022.
Warning: These citations may not always be 100% accurate.